Gene: SRSF8
Official Full Name: serine and arginine rich splicing factor 8provided by HGNC
Gene Summary: This gene encodes a member of a family of proteins containing a ribonucleoprotein (RNP)-type RNA binding motif and a carboxyl-terminal arginine-serine-rich (RS) domain. The encoded protein functions as a pre-mRNA splicing factor. There is a pseudogene for this gene on chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO31405 | SRSF8 Knockout cell line (HeLa) | Human | SRSF8 | 1:3~1:6 | Negative | Online Inquiry |
KO31406 | SRSF8 Knockout cell line (HCT 116) | Human | SRSF8 | 1:2~1:4 | Negative | Online Inquiry |
KO31407 | SRSF8 Knockout cell line (HEK293) | Human | SRSF8 | 1:3~1:6 | Negative | Online Inquiry |
KO31408 | SRSF8 Knockout cell line (A549) | Human | SRSF8 | 1:3~1:4 | Negative | Online Inquiry |
SRSF8 Gene Knockout Cell Lines are specialized cellular models engineered to selectively disrupt the expression of the serine/arginine-rich splicing factor 8 (SRSF8) gene. This gene is known to play a pivotal role in pre-mRNA splicing, influencing mRNA maturation, and cellular responses to various stress conditions. By creating a knockout model, researchers can study the implications of SRSF8 gene disruption on cellular physiology, gene expression regulation, and splicing mechanisms.
The primary function of SRSF8 involves its participation in the splicing of pre-mRNA into mature mRNA, as well as its involvement in the regulation of alternative splicing events that can lead to the production of diverse protein isoforms. These knockout cell lines operate by employing CRISPR/Cas9 technology or similar genome-editing techniques to achieve a precise alteration of the SRSF8 gene, providing researchers with a clear window to analyze the resulting phenotypic changes, molecular pathways, and potential compensatory mechanisms within the cell.
The scientific significance of SRSF8 Gene Knockout Cell Lines extends to various fields such as cancer research, neurobiology, and developmental biology. By utilizing these cell lines, researchers can gain insights into the role of SRSF8 in diseases where alternative splicing is disrupted and can explore therapeutic interventions that target splicing anomalies. These models are critical for understanding the broader implications of splicing factors in disease pathology and cellular differentiation processes.
What sets SRSF8 Gene Knockout Cell Lines apart from other alternatives is their precision and reliability. Each line undergoes rigorous validation to confirm gene disruption and functional alterations, ensuring reproducibility in experimental results. Additionally, our product is supported by comprehensive technical documentation and protocols, facilitating easy integration into existing research workflows.
For researchers and clinicians focused on advancing molecular biology, neurobiology, or cancer therapeutics, SRSF8 Gene Knockout Cell Lines provide a valuable resource for innovative discovery. They are instrumental in elucidating the complexities of gene regulation and cellular responses, ultimately leading to significant advancements in therapeutic development. With our extensive experience and commitment to scientific excellence, we are dedicated to providing high-quality biological products that empower researchers to drive meaningful discoveries.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.